Bio Preventive Medicine Corp.
6810
Rank in Stocks
#24563
Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical... Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical development phase, specializes in the proactive identification and mitigation of various illnesses. The company develops comprehensive strategies for the prevention, screening, and ongoing oversight of chronic conditions and cancer treatment. A key offering is the DNlite test, a suite of proprietary and medically validated non-intrusive urine analyses designed to aid in the management of diabetic kidney disease, encompassing specific products like DNlite-IVD103 and DNlite-DN_Score. Established in 2014, its main operations are located in Zhubei, Taiwan.
Share Price
$0.65084319
Last synced: 2026-11-10
Market Cap
$32.18M
Change (1 day)
2.64%
Change (1 year)
-18.11%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bio Preventive Medicine Corp. (6810)
Category
Healthcare
Operating Margin for Bio Preventive Medicine Corp. (6810)
Operating Margin as of November 2026 TTM: -3,244.88%
According to Bio Preventive Medicine Corp.'s latest financial reports, its current operating margin (TTM) is -3,244.88%. At the end of 2025 the company had an operating margin of -3,832.05%.
Operating Margin history for Bio Preventive Medicine Corp. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -3,244.88% | -15.32% |
| 2025 | -3,832.05% | 449.45% |
| 2024 | -697.44% | -88.39% |
| 2023 | -6,006.95% | 84.68% |
| 2022 | -3,252.69% | -57.65% |
| 2021 | -7,680.62% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.01% |
US
|
|
| -149.01% | -99.95% |
US
|
|
| 25.57% | -100.01% |
AU
|
|
| 31.23% | -100.01% |
BE
|
|
| 29.35% | -100.01% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bio Preventive Medicine Corp.'s operating margin
What is Bio Preventive Medicine Corp.'s operating margin?
Bio Preventive Medicine Corp.'s operating margin is -3,244.88%, as of Nov 2026.
What was Bio Preventive Medicine Corp.'s operating margin in 2025?
In 2025, Bio Preventive Medicine Corp.'s operating margin was -3,832.05%, compared with -697.44% in 2024.
How has Bio Preventive Medicine Corp.'s operating margin changed since 2020?
From 2020 to 2025, Bio Preventive Medicine Corp.'s operating margin was highest in 2020 (0.00%) and lowest in 2021 (-7,680.62%).
How does Bio Preventive Medicine Corp.'s operating margin compare with similar companies?
Bio Preventive Medicine Corp.'s operating margin (-3,244.88%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.